Basile, M., F. Rumi, and A. Cicchetti. “Budget Impact Analysis of Ponatinib for the Management of Patients With Chronic Myeloid Leukemia”. Global and Regional Health Technology Assessment, vol. 8, no. 1, July 2021, pp. 87-95, doi:10.33393/grhta.2021.2238.